Update on persistent acute kidney injury in critical illnesses.
Sara SamoniSilvia De RosaClaudio RoncoGiuseppe CastellanoPublished in: Clinical kidney journal (2023)
Acute kidney injury (AKI) affects about half of patients admitted to the intensive care unit (ICU), and worsens their short- and long-term outcomes. Apparently self-limiting AKI episodes initiate a progression toward chronic kidney disease (CKD) through cellular and molecular mechanisms that are yet to be explained. In particular, persistent AKI, defined in 2016 by the Acute Dialysis Quality Initiative as an AKI which lasts more than 48 h from its onset, has been correlated with higher morbidity and mortality, and with a higher progression to acute kidney disease (AKD) and CKD than transient AKI (i.e. AKI with a reversal within 48 h). This classification has been also used in the setting of solid organ transplantation, demonstrating similar outcomes. Due to its incidence and poor prognosis and because prompt interventions seem to change its course, persistent AKI should be recognized early and followed-up also after its recovery. However, while AKI and CKD are well-described syndromes, persistent AKI and AKD are relatively new entities. The purpose of this review is to highlight the key phases of persistent AKI in ICU patients in terms of both clinical and mechanistic features in order to offer to clinicians and researchers an updated basis from which to start improving patients' care and direct future research.
Keyphrases
- acute kidney injury
- chronic kidney disease
- end stage renal disease
- cardiac surgery
- poor prognosis
- peritoneal dialysis
- ejection fraction
- newly diagnosed
- quality improvement
- palliative care
- prognostic factors
- healthcare
- type diabetes
- deep learning
- mesenchymal stem cells
- drug induced
- current status
- brain injury
- pain management
- cell therapy
- hepatitis b virus
- weight loss
- subarachnoid hemorrhage
- acute respiratory distress syndrome